Research graph
References from A case report of a composite pheochromocytoma that occurred 13 years after adrenalectomy for pheochromocytoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Composite pheochromocytoma of the adrenal gland-a review of published cases
10.1007/s00428-023-03492-y · 2023 · External reference
Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours
10.1007/s12022-017-9484-5 · 2017 · External reference
Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors: a case series with comparative analysis
10.4158/ep14010.or · 2014 · External reference
Composite pheochromocytoma/paraganglioma-ganglioneuroma: a clinicopathologic study of eight cases with analysis of succinate dehydrogenase
10.1007/s12022-017-9494-3 · 2017 · External reference
Adrenal ganglioneuroma: prognostic factors (review)
10.3892/etm.2021.10773 · 2021 · External reference
Composite phaeochromocytomas-a systematic review of published literature
10.1007/s00423-021-02129-5 · 2022 · External reference
Case report: Composite pheochromocytoma with ganglioneuroma component: a report of three cases
10.3389/fendo.2022.903085 · 2022 · External reference
Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center
10.1007/s12020-018-1734-x · 2018 · External reference
Adrenal neurofibroma masquerading as phaeochromocytoma
10.4103/ijemcr.ijemcr_56_24 · 2024 · External reference
Composite pheochromocytoma-ganglioneuroma: a rare experiment of nature
10.4158/ep09205.ra · 2010 · External reference
Silent catalyst: undiagnosed pheochromocytoma triggering acute aortic dissection
10.4103/ijemcr.ijemcr_2_25 · 2025 · External reference
Hormone-secreting large adrenal ganglioneuroma in an adult patient: a case report and review of literature
10.3109/08037051.2013.796103 · 2014 · External reference
Composite pheochromocytoma-ganglioneuroma of the adrenal gland: a case report with immunohistochemical study
10.4103/0974-7796.110011 · 2013 · External reference
Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas
10.1007/s12022-022-09704-6 · 2022 · External reference
Composite pheochromocytomas: more common than expected and associated with distinct clinical profile
10.1016/j.eprac.2026.05.008 · 2026 · External reference
A novel MAX gene mutation variant in a patient with multiple and "composite" neuroendocrine-neuroblastic tumors
10.3389/fendo.2020.00234 · 2020 · External reference
Pheochromocytoma
10.2478/enr-2019-0020 · 2019 · External reference
Images in endocrine pathology: progressive loss of sustentacular cells in a case of recurrent jugulotympanic paraganglioma over a span of 5 years
10.1007/s12022-020-09632-3 · 2020 · External reference
Validation and evaluation of 5 scoring systems for predicting metastatic risk in pheochromocytoma and paraganglioma
10.1097/pas.0000000000002238 · 2024 · External reference
Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
10.1080/07853890.2025.2478312 · 2025 · External reference
Results of surgery for a compound adrenal tumor consisting of pheochromocytoma and ganglioneuroblastoma in an adult: 5-year follow-up
10.2169/internalmedicine.39.58 · 2000 · External reference
COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas
10.1007/s00428-019-02553-5 · 2019 · External reference
